quality control review & editing services

Delivering an unparalleled attention to detail

Woman pointing to a computer monitor and writing on a paper

Detailed and comprehensive quality control (QC) reviews (or data verification reviews) and editing are an integral part of the production lifecycle of a document, rather than a one-off step in the development process. Mistakes and inconsistencies in a document can call into question the validity of the content or result in an incorrect interpretation of the data.

ProPharma’s team of seasoned QC reviewers/editors provides quality review and editing services across a wide array of documents and therapeutic areas.

Ready to Speak to a Quality Control Reviewer/Editor?

Quality Control Review/Editing Services

ProPharma QC reviewers/editors perform targeted or comprehensive quality control reviews of documents to ensure accuracy, integrity, and consistency of both data and messaging.

Quality control reviews and/or editorial reviews are performed on any deliverable, in any therapeutic area, using either client checklists or our internal document-specific checklists to ensure the quality and consistency both within and across documents.

Professional medical editors conversing around table.

Quality Control Review:
Data Verification

ProPharma QC reviewers/editors provide 100% source verification of all data in both document text and in-text tables, as necessary. Data verification review is offered in addition to editorial review or as a standalone service.

Editorial Review:
No Data Verification

ProPharma QC reviewers/editors provide a complete editorial review to ensure consistency, clarity of message, and appropriate implementation of style and template requirements. Editorial review includes general copy editing and review of abbreviations, internal cross references, and citations, and is offered in addition to data verification review or as a standalone service.


Benefits of Working with Our Quality Control Review/Editing Team

Global submission icon

GLOBAL AND EXPERIENCED

ProPharma QC reviewers/editors are located across North America, Europe, and India. They have an average of 10 years of experience spanning multiple therapy areas and domains.

Full Service Clinical Trials icon

FLEXIBLE AND SCALABLE

With access to a large pool of experienced resources, we are responsive to changes in workload and can scale as needed to accommodate variable client demands and volume.

Compliance

COMPREHENSIVE AND THOROUGH

We perform comprehensive reviews of each document using detailed document-specific checklists to ensure quality and consistency within and across documents.

Quality Control Review Frequently Asked Questions

Click on frequently asked questions about ProPharma's quality control review and editing services to learn about our experience and expertise.

Yes, ProPharma QC reviewers/editors accommodate last-minute and drop-in QC requests as needed.

ProPharma understands that timelines shift, projects get cancelled, and that shifting timelines are a potential risk in any project. ProPharma remains flexible and mitigates this risk through consistent project and resource management. Resource availability and project status are routinely reviewed and updated, allowing us to adapt in real time and overcome any potential challenges, including timeline shifts.

If a project shifts out significantly, we work with clients to map out a plan that ensures both timely delivery and service continuity. We take steps to ensure (to the extent possible) the same person can re-engage on the project once it becomes active again. If timelines accelerate, we can provide additional resources, as needed, to ensure timeline integrity.

ProPharma can utilize either our internal QC SOPs or client SOPs.

Yes. ProPharma has both general and document-specific QC checklists.

Yes, ProPharma QC reviewers/editors provide consistent application of general and/or client-specific style guides (including therapeutic area-specific style guides, as applicable).

Have questions? We'd be happy to talk with you
about your unique needs and goals.

News & Insights

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Next

November 20, 2025

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Nex...

Learn how to identify the warning signs of a failing pharmacovigilance vendor and navigate the rescue process to ensure program success.

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Next

November 20, 2025

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Nex...

Learn how to identify the warning signs of a failing pharmacovigilance vendor and navigate the rescue process to ensure program success.

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow